THAP1
Role in focal dystonia?
Citation Manager Formats
Make Comment
See Comments

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Primary torsion dystonia (PTD) is characterized by sustained muscle contractions that cause twisting and repetitive movements, where dystonia is the only or predominant clinical feature. The clinical spectrum associated with PTD is remarkably broad. Symptoms may begin at any age and severity ranges from involvement of a single muscle to generalized contractions of the limb, axial, and cranial muscles. When PTD begins in childhood, it often progresses to involve multiple body regions. When PTD begins in adult years, dystonia tends to remain localized with a focal or segmental distribution. The prevalence of PTD has been estimated between 330 per million to 152 per million, the great majority being focal.1
Seven genes have been mapped for primary dystonia including DYT1, 2, 4, 6, 7, 13, and 172; however, only 2 of these genes have been identified: TOR1A (DYT1)3 and the recently described THAP1 (DYT6) gene.4 A 3-bp (GAG) deletion in the coding region of the TOR1A gene is a major cause of childhood onset, generalized dystonia that usually begins in a limb.3 DYT6 dystonia was described in three Amish-Mennonite families who share a disease haplotype that could be traced to a …
AAN Members: Sign in with your AAN member credentials (e-mail or 6-digit Member ID number)
Non-AAN Member subscribers: Sign in with subscriber credentials
Log in using your username and password
Purchase access
AAN members must change their passwords on the AAN site
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page.
Access for 1 day (from the computer you are currently using) is US$ 39.00.
Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means.
The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Disputes & Debates: Rapid online correspondence
NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within the last 8 weeks.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.